Skip to main content
Erschienen in: Pathology & Oncology Research 2/2011

01.06.2011 | Research

The Role of Viral Infections in the Development of Dilated Cardiomyopathy

verfasst von: Enikő Tátrai, István Hartyánszky Jr., András Lászik, György Acsády, Péter Sótonyi, Márta Hubay

Erschienen in: Pathology & Oncology Research | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

Enteroviruses (EVs) are the most frequent pathogens in myocarditis and in the subsequently developing dilated cardiomyopathy as well. Furthermore, persistence of other viruses might play a pathogenic role in the evolution from myocarditis to dilated cardiomyopathy. Explanted heart of 28 patients, who underwent heart transplantation were screened for EV, AdV3 and HHV6 sequences in order to assess the incidence of cardiac viral infection that may be implicated in the pathogenesis of cardiomyopathy, and estimate viral distribution in the myocardium. Viral sequences were extracted from five different regions of the hearts. Nested PCR was used to amplify conservative regions of AdV3, HHV6 and EVs. Histological examination was performed on routinely processed myocardial samples. AdV3 was verified in one fourth of the patients. ADV3 and HHV6 sequences coexisted in one case with inflammatory cardiomyopathy. Some patients had more than one positive area of their heart. AdV3 positive right ventricular samples were double in amount compared to the left ones. None of the patients had positive result for EV. This is the first occasion to identify AdV3 (a mainly respiratory infective virus) sequence in explanted hearts of cardiomyopathy patients. Though the clinical importance of our results is still unclear, AdV3 could be a new member of the viral group with possible pathogenic effect on the myocardium. Regional distribution of viral sequence location confirmed that the right ventricular wall as a biopsy sampling site might be adequate for endomyocardial biopsy pro diagnostic purposes.
Literatur
2.
Zurück zum Zitat Brandenburg RO, Chazov E, Cherian G et al (1980) Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Br Heart J 44(6):672–673CrossRef Brandenburg RO, Chazov E, Cherian G et al (1980) Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Br Heart J 44(6):672–673CrossRef
3.
Zurück zum Zitat Richardson P, McKenna W, Bristow M et al (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 93(5):841–842PubMed Richardson P, McKenna W, Bristow M et al (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 93(5):841–842PubMed
4.
Zurück zum Zitat Mason JW (2003) Myocarditis and dilated cardiomyopathy: an inflammatory link. Cardiovasc Res 60(1):5–10PubMedCrossRef Mason JW (2003) Myocarditis and dilated cardiomyopathy: an inflammatory link. Cardiovasc Res 60(1):5–10PubMedCrossRef
5.
Zurück zum Zitat Bowles NE, Ni J, Kearney DL et al (2003) Detection of viruses in myocardial tissues by polymerase chain reaction: evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 42(3):466–472PubMedCrossRef Bowles NE, Ni J, Kearney DL et al (2003) Detection of viruses in myocardial tissues by polymerase chain reaction: evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 42(3):466–472PubMedCrossRef
6.
Zurück zum Zitat Basso C, Calabrese F, Corrado D et al (2001) Postmortem diagnosis in sudden cardiac death victims: macroscopic, microscopic and molecular findings. Cardiovasc Res 50(2):290–300PubMedCrossRef Basso C, Calabrese F, Corrado D et al (2001) Postmortem diagnosis in sudden cardiac death victims: macroscopic, microscopic and molecular findings. Cardiovasc Res 50(2):290–300PubMedCrossRef
7.
Zurück zum Zitat Francalanci P, Chance JL, Vatta M et al (2004) Cardiotropic viruses in the myocardium of children with end-stage heart disease. J Heart Lung Transplant 23(9):1046–1052PubMedCrossRef Francalanci P, Chance JL, Vatta M et al (2004) Cardiotropic viruses in the myocardium of children with end-stage heart disease. J Heart Lung Transplant 23(9):1046–1052PubMedCrossRef
8.
Zurück zum Zitat Woodruff JF (1980) Viral myocarditis. A review. Am J Pathol 101(2):425–484PubMed Woodruff JF (1980) Viral myocarditis. A review. Am J Pathol 101(2):425–484PubMed
9.
Zurück zum Zitat Comar M, D'Agaro P, Campello C et al (2009) Human herpes virus 6 in archival cardiac tissues from children with idiopathic dilated cardiomyopathy or congenital heart disease. J Clin Pathol 62(1):80–83PubMedCrossRef Comar M, D'Agaro P, Campello C et al (2009) Human herpes virus 6 in archival cardiac tissues from children with idiopathic dilated cardiomyopathy or congenital heart disease. J Clin Pathol 62(1):80–83PubMedCrossRef
10.
Zurück zum Zitat Fukae S, Ashizawa N, Morikawa S et al (2000) A fatal case of fulminant myocarditis with human herpesvirus-6 infection. Intern Med 39(8):632–636PubMedCrossRef Fukae S, Ashizawa N, Morikawa S et al (2000) A fatal case of fulminant myocarditis with human herpesvirus-6 infection. Intern Med 39(8):632–636PubMedCrossRef
11.
Zurück zum Zitat Rohayem J, Dinger J, Fischer R et al (2001) Fatal myocarditis associated with acute parvovirus B19 and human herpesvirus 6 coinfection. J Clin Microbiol 39(12):4585–4587PubMedCrossRef Rohayem J, Dinger J, Fischer R et al (2001) Fatal myocarditis associated with acute parvovirus B19 and human herpesvirus 6 coinfection. J Clin Microbiol 39(12):4585–4587PubMedCrossRef
12.
Zurück zum Zitat Yoshikawa T, Ihira M, Suzuki K et al (2001) Fatal acute myocarditis in an infant with human herpesvirus 6 infection. J Clin Pathol 54(10):792–795PubMedCrossRef Yoshikawa T, Ihira M, Suzuki K et al (2001) Fatal acute myocarditis in an infant with human herpesvirus 6 infection. J Clin Pathol 54(10):792–795PubMedCrossRef
13.
Zurück zum Zitat Savon C, Acosta B, Valdes O et al (2008) A myocarditis outbreak with fatal cases associated with adenovirus subgenera C among children from Havana City in 2005. J Clin Virol 43(2):152–157PubMedCrossRef Savon C, Acosta B, Valdes O et al (2008) A myocarditis outbreak with fatal cases associated with adenovirus subgenera C among children from Havana City in 2005. J Clin Virol 43(2):152–157PubMedCrossRef
14.
Zurück zum Zitat James L, Vernon MO, Jones RC et al (2007) Outbreak of human adenovirus type 3 infection in a pediatric long-term care facility–Illinois, 2005. Clin Infect Dis 45(4):416–420PubMedCrossRef James L, Vernon MO, Jones RC et al (2007) Outbreak of human adenovirus type 3 infection in a pediatric long-term care facility–Illinois, 2005. Clin Infect Dis 45(4):416–420PubMedCrossRef
15.
Zurück zum Zitat Herbert FA, Wilkinson D, Burchak E et al (1977) Adenovirus type 3 pneumonia causing lung damage in childhood. Can Med Assoc J 116(3):274–276PubMed Herbert FA, Wilkinson D, Burchak E et al (1977) Adenovirus type 3 pneumonia causing lung damage in childhood. Can Med Assoc J 116(3):274–276PubMed
16.
17.
Zurück zum Zitat Caforio AL (1994) Role of autoimmunity in dilated cardiomyopathy. Br Heart J 72(6 Suppl):S30–34PubMedCrossRef Caforio AL (1994) Role of autoimmunity in dilated cardiomyopathy. Br Heart J 72(6 Suppl):S30–34PubMedCrossRef
18.
Zurück zum Zitat Martin AB, Webber S, Fricker FJ et al (1994) Acute myocarditis. Rapid diagnosis by PCR in children. Circulation 90(1):330–339PubMed Martin AB, Webber S, Fricker FJ et al (1994) Acute myocarditis. Rapid diagnosis by PCR in children. Circulation 90(1):330–339PubMed
19.
Zurück zum Zitat Bowles NE, Kearney DL, Ni J et al (1999) The detection of viral genomes by polymerase chain reaction in the myocardium of pediatric patients with advanced HIV disease. J Am Coll Cardiol 34(3):857–865PubMedCrossRef Bowles NE, Kearney DL, Ni J et al (1999) The detection of viral genomes by polymerase chain reaction in the myocardium of pediatric patients with advanced HIV disease. J Am Coll Cardiol 34(3):857–865PubMedCrossRef
20.
Zurück zum Zitat Pauschinger M, Bowles NE, Fuentes-Garcia FJ et al (1999) Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation 99(10):1348–1354PubMed Pauschinger M, Bowles NE, Fuentes-Garcia FJ et al (1999) Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation 99(10):1348–1354PubMed
21.
Zurück zum Zitat Rey L, Lambert V, Wattre P et al (2001) Detection of enteroviruses ribonucleic acid sequences in endomyocardial tissue from adult patients with chronic dilated cardiomyopathy by a rapid RT-PCR and hybridization assay. J Med Virol 64(2):133–140PubMedCrossRef Rey L, Lambert V, Wattre P et al (2001) Detection of enteroviruses ribonucleic acid sequences in endomyocardial tissue from adult patients with chronic dilated cardiomyopathy by a rapid RT-PCR and hybridization assay. J Med Virol 64(2):133–140PubMedCrossRef
22.
Zurück zum Zitat Donoso Mantke O, Nitsche A, Meyer R et al (2004) Analysing myocardial tissue from explanted hearts of heart transplant recipients and multi-organ donors for the presence of parvovirus B19 DNA. J Clin Virol 31(1):32–39PubMedCrossRef Donoso Mantke O, Nitsche A, Meyer R et al (2004) Analysing myocardial tissue from explanted hearts of heart transplant recipients and multi-organ donors for the presence of parvovirus B19 DNA. J Clin Virol 31(1):32–39PubMedCrossRef
23.
Zurück zum Zitat Suedkamp M, Lissel C, Eiffert H et al (1999) Cardiac myocytes of hearts from patients with end-stage dilated cardiomyopathy do not contain Borrelia burgdorferi DNA. Am Heart J 138(2 Pt 1):269–272PubMedCrossRef Suedkamp M, Lissel C, Eiffert H et al (1999) Cardiac myocytes of hearts from patients with end-stage dilated cardiomyopathy do not contain Borrelia burgdorferi DNA. Am Heart J 138(2 Pt 1):269–272PubMedCrossRef
24.
Zurück zum Zitat Tátrai E, Hartyánszky I, Lászik A et al (2007) Molecular biological virus identification in dilated cardiomyopathy. Orvosi Hetilap 148(48):2275–2278PubMedCrossRef Tátrai E, Hartyánszky I, Lászik A et al (2007) Molecular biological virus identification in dilated cardiomyopathy. Orvosi Hetilap 148(48):2275–2278PubMedCrossRef
25.
Zurück zum Zitat Mahrholdt H, Wagner A, Deluigi CC et al (2006) Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 114(15):1581–1590PubMedCrossRef Mahrholdt H, Wagner A, Deluigi CC et al (2006) Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 114(15):1581–1590PubMedCrossRef
26.
Zurück zum Zitat Hauck AJ, Kearney DL, Edwards WD (1989) Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error. Mayo Clin Proc 64(10):1235–1245PubMed Hauck AJ, Kearney DL, Edwards WD (1989) Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error. Mayo Clin Proc 64(10):1235–1245PubMed
27.
Zurück zum Zitat Kuhl U, Pauschinger M, Noutsias M et al (2005) High prevalence of viral genomes and multiple viral infections in the myocardium of adults with “idiopathic” left ventricular dysfunction. Circulation 111(7):887–893PubMedCrossRef Kuhl U, Pauschinger M, Noutsias M et al (2005) High prevalence of viral genomes and multiple viral infections in the myocardium of adults with “idiopathic” left ventricular dysfunction. Circulation 111(7):887–893PubMedCrossRef
28.
Zurück zum Zitat Kuhl U, Pauschinger M, Schwimmbeck PL et al (2003) Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 107(22):2793–2798PubMedCrossRef Kuhl U, Pauschinger M, Schwimmbeck PL et al (2003) Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 107(22):2793–2798PubMedCrossRef
29.
Zurück zum Zitat Maekawa Y, Ouzounian M, Opavsky MA et al (2007) Connecting the missing link between dilated cardiomyopathy and viral myocarditis: virus, cytoskeleton, and innate immunity. Circulation 115(1):5–8PubMedCrossRef Maekawa Y, Ouzounian M, Opavsky MA et al (2007) Connecting the missing link between dilated cardiomyopathy and viral myocarditis: virus, cytoskeleton, and innate immunity. Circulation 115(1):5–8PubMedCrossRef
30.
Zurück zum Zitat Lawson CM (2000) Evidence for mimicry by viral antigens in animal models of autoimmune disease including myocarditis. Cell Mol Life Sci 57(4):552–560PubMedCrossRef Lawson CM (2000) Evidence for mimicry by viral antigens in animal models of autoimmune disease including myocarditis. Cell Mol Life Sci 57(4):552–560PubMedCrossRef
31.
Zurück zum Zitat Heymans S, Pauschinger M, De Palma A et al (2006) Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis. Circulation 114(6):565–573PubMedCrossRef Heymans S, Pauschinger M, De Palma A et al (2006) Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis. Circulation 114(6):565–573PubMedCrossRef
32.
Zurück zum Zitat Caforio AL, Grazzini M, Mann JM et al (1992) Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 85(5):1734–1742PubMed Caforio AL, Grazzini M, Mann JM et al (1992) Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 85(5):1734–1742PubMed
33.
Zurück zum Zitat Caruso A, Rotola A, Comar M et al (2002) HHV-6 infects human aortic and heart microvascular endothelial cells, increasing their ability to secrete proinflammatory chemokines. J Med Virol 67(4):528–533PubMedCrossRef Caruso A, Rotola A, Comar M et al (2002) HHV-6 infects human aortic and heart microvascular endothelial cells, increasing their ability to secrete proinflammatory chemokines. J Med Virol 67(4):528–533PubMedCrossRef
34.
Zurück zum Zitat Horvath R, Cerny J, Benedik J et al (2000) The possible role of human cytomegalovirus (HCMV) in the origin of atherosclerosis. J Clin Virol 16(1):17–24PubMedCrossRef Horvath R, Cerny J, Benedik J et al (2000) The possible role of human cytomegalovirus (HCMV) in the origin of atherosclerosis. J Clin Virol 16(1):17–24PubMedCrossRef
35.
Zurück zum Zitat Ismail A, Khosravi H, Olson H (1999) The role of infection in atherosclerosis and coronary artery disease: a new therapeutic target. Heart Dis 1(4):233–240PubMed Ismail A, Khosravi H, Olson H (1999) The role of infection in atherosclerosis and coronary artery disease: a new therapeutic target. Heart Dis 1(4):233–240PubMed
36.
Zurück zum Zitat Andreoletti L, Hober D, Decoene C et al (1996) Detection of enteroviral RNA by polymerase chain reaction in endomyocardial tissue of patients with chronic cardiac diseases. J Med Virol 48(1):53–59PubMedCrossRef Andreoletti L, Hober D, Decoene C et al (1996) Detection of enteroviral RNA by polymerase chain reaction in endomyocardial tissue of patients with chronic cardiac diseases. J Med Virol 48(1):53–59PubMedCrossRef
37.
Zurück zum Zitat Petitjean J, Kopecka H, Freymuth F et al (1992) Detection of enteroviruses in endomyocardial biopsy by molecular approach. J Med Virol 37(1):76–82PubMedCrossRef Petitjean J, Kopecka H, Freymuth F et al (1992) Detection of enteroviruses in endomyocardial biopsy by molecular approach. J Med Virol 37(1):76–82PubMedCrossRef
38.
Zurück zum Zitat de Leeuw N, Melchers WJ, Balk AH et al (1998) No evidence for persistent enterovirus infection in patients with end-stage idiopathic dilated cardiomyopathy. J Infect Dis 178(1):256–259PubMedCrossRef de Leeuw N, Melchers WJ, Balk AH et al (1998) No evidence for persistent enterovirus infection in patients with end-stage idiopathic dilated cardiomyopathy. J Infect Dis 178(1):256–259PubMedCrossRef
39.
Zurück zum Zitat Mahon NG, Zal B, Arno G et al (2001) Absence of viral nucleic acids in early and late dilated cardiomyopathy. Heart 86(6):687–692PubMedCrossRef Mahon NG, Zal B, Arno G et al (2001) Absence of viral nucleic acids in early and late dilated cardiomyopathy. Heart 86(6):687–692PubMedCrossRef
40.
Zurück zum Zitat Weiss LM, Liu XF, Chang KL et al (1992) Detection of enteroviral RNA in idiopathic dilated cardiomyopathy and other human cardiac tissues. J Clin Invest 90(1):156–159PubMedCrossRef Weiss LM, Liu XF, Chang KL et al (1992) Detection of enteroviral RNA in idiopathic dilated cardiomyopathy and other human cardiac tissues. J Clin Invest 90(1):156–159PubMedCrossRef
41.
Zurück zum Zitat Maron BJ, Towbin JA, Thiene G et al (2006) Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113(14):1807–1816PubMedCrossRef Maron BJ, Towbin JA, Thiene G et al (2006) Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113(14):1807–1816PubMedCrossRef
42.
Zurück zum Zitat Osterziel KJ, Scheffold T, Perrot A et al (2001) Genetics of dilated cardiomyopathy. Z Kardiol 90(7):461–469PubMedCrossRef Osterziel KJ, Scheffold T, Perrot A et al (2001) Genetics of dilated cardiomyopathy. Z Kardiol 90(7):461–469PubMedCrossRef
Metadaten
Titel
The Role of Viral Infections in the Development of Dilated Cardiomyopathy
verfasst von
Enikő Tátrai
István Hartyánszky Jr.
András Lászik
György Acsády
Péter Sótonyi
Márta Hubay
Publikationsdatum
01.06.2011
Verlag
Springer Netherlands
Erschienen in
Pathology & Oncology Research / Ausgabe 2/2011
Print ISSN: 1219-4956
Elektronische ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-010-9302-6

Weitere Artikel der Ausgabe 2/2011

Pathology & Oncology Research 2/2011 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.